| URL | http://www.businesswire.com/news/home/201511250051 |
| Source | Business Wire |
| Date Published | 11/25/2015 |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | Xellia Pharmaceuticals |
| Type of work | Manufacturing |
| Reshoring category: | Transplant |
| Year reshoring announced: | 2015 |
| Country(ies) from which reshored: | Denmark |
| City reshored to: | Bedford |
| State(s) reshored to: | OH |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | Anti-Infective Pharmaceuticals |
| What domestic positive factors made reshoring more attractive? | Proximity to customers/market |